156 related articles for article (PubMed ID: 1716864)
1. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
Jans DA; Resink TJ; Hemmings BA
Arch Biochem Biophys; 1991 Mar; 285(2):377-81. PubMed ID: 1716864
[TBL] [Abstract][Full Text] [Related]
2. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.
Jans DA; Resink TJ; Hemmings BA
Biochem J; 1987 Apr; 243(2):413-8. PubMed ID: 2820380
[TBL] [Abstract][Full Text] [Related]
3. Long-term stimulation of cAMP production in LLC-PK1 pig kidney epithelial cells by salmon calcitonin or a photoactivatable analogue of vasopressin.
Jans DA; Gajdas EL; Dierks-Ventling C; Hemmings BA; Fahrenholz F
Biochim Biophys Acta; 1987 Oct; 930(3):392-400. PubMed ID: 2820505
[TBL] [Abstract][Full Text] [Related]
4. Histidine regulation of cyclic AMP metabolism in cultured renal epithelial LLC-PK1 cells.
Dixon BS; Breckon R; Kaehny MM; Dillingham MA; Anderson RJ
J Biol Chem; 1990 Jan; 265(2):760-6. PubMed ID: 1688553
[TBL] [Abstract][Full Text] [Related]
5. A system to select for mutant LLC-PK1 cells affected in cAMP mediated hormonal response using a photoactivatable analogue of vasopressin.
Luzius H; Jans DA; Fahrenholz F
J Recept Res; 1990; 10(1-2):61-80. PubMed ID: 2175811
[TBL] [Abstract][Full Text] [Related]
6. cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells.
Jans DA; Hemmings BA
FEBS Lett; 1991 Apr; 281(1-2):267-71. PubMed ID: 1707831
[TBL] [Abstract][Full Text] [Related]
7. Complementation between LLC-PK1 mutants affected in polypeptide hormone-receptor function.
Jans DA; Resink TJ; Hemmings BA
Eur J Biochem; 1987 Feb; 162(3):571-6. PubMed ID: 3030741
[TBL] [Abstract][Full Text] [Related]
8. Codominant expression of a mutation affecting the cAMP-dependent protein kinase catalytic subunit in somatic cell hybrids of LLC-PK1 cells.
Jans DA; Botterell SH; Hemmings BA
Exp Cell Res; 1988 May; 176(1):129-40. PubMed ID: 3286277
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptor.
Jans DA; Pavo I; Fahrenholz F
FEBS Lett; 1993 Jan; 315(2):134-8. PubMed ID: 8380270
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cyclic AMP-dependent protein kinase by vasopressin and calcitonin in cultured porcine renal LLC-PK1 cells.
Ausiello DA; Hall DH; Dayer JM
Biochem J; 1980 Mar; 186(3):773-80. PubMed ID: 6249260
[TBL] [Abstract][Full Text] [Related]
11. cAMP stimulates protein kinase C activity in cultured renal LLC-PK1 cells.
Anderson RJ; Breckon R
Am J Physiol; 1991 Dec; 261(6 Pt 2):F945-50. PubMed ID: 1661084
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function.
Jans DA; Resink TJ; Wilson LE; Reich E; Hemmings BA
Eur J Biochem; 1986 Oct; 160(2):407-12. PubMed ID: 3021458
[TBL] [Abstract][Full Text] [Related]
13. cAMP mediated proteolysis of the catalytic subunit of cAMP-dependent protein kinase.
Hemmings BA
FEBS Lett; 1986 Feb; 196(1):126-30. PubMed ID: 2417885
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta 1 regulation of signal transduction in two renal epithelial cell lines.
Anderson RJ; Sponsel HT; Breckon R; Marcell T; Hoeffler JP
Am J Physiol; 1993 Oct; 265(4 Pt 2):F584-91. PubMed ID: 8238388
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells.
Goldberg H; Clayman P; Skorecki K
Am J Physiol; 1988 Nov; 255(5 Pt 2):F995-1002. PubMed ID: 2461098
[TBL] [Abstract][Full Text] [Related]
16. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function.
Luzius H; Jans DA; Jans P; Fahrenholz F
Exp Cell Res; 1991 Aug; 195(2):478-84. PubMed ID: 1649058
[TBL] [Abstract][Full Text] [Related]
17. ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV.
Yamaki M; McIntyre S; Murphy JM; Swinnen JV; Conti M; Dousa TP
Kidney Int; 1993 Jun; 43(6):1286-97. PubMed ID: 8391097
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
Litvin Y; Leiser M; Fleischer N; Erlichman J
Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
[TBL] [Abstract][Full Text] [Related]
19. Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor.
Jans DA; Jans P; Luzius H; Fahrenholz F
Mol Cell Endocrinol; 1991 Oct; 81(1-3):165-74. PubMed ID: 1797584
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone (PTH)/PTH-related peptide receptor density modulates activation of phospholipase C and phosphate transport by PTH in LLC-PK1 cells.
Guo J; Iida-Klein A; Huang X; Abou-Samra AB; Segre GV; Bringhurst FR
Endocrinology; 1995 Sep; 136(9):3884-91. PubMed ID: 7649096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
